How competition governs whether moderate or aggressive treatment minimizes antibiotic resistance
Understanding how our use of antimicrobial drugs shapes future levels of drug resistance is crucial. Recently, there has been debate over whether an aggressive (i.e., high dose) or more moderate (i.e., lower dose) treatment of individuals will most limit the emergence and spread of resistant bacteri...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2015-09-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/10559 |